Navigation Links
Meditope Biosciences Appoints Prominent Scientific Advisory Board
Date:1/14/2014

ciples for the sequence specific recognition of DNA.
  • Iqbal S. Grewal, PhD, DSc, FRCPath, Chief Scientific Officer and a director of ImmunGene, Inc.  Prior to joining ImmunGene, Dr. Grewal served as Vice President of Preclinical Therapeutics at Seattle Genetics, where he managed preclinical translational research functions for development of monoclonal antibodies and antibody-drug conjugates as therapeutics in the areas of oncology and autoimmunity.  His career also includes discovery research and preclinical development of biologics at Genentech, as well as various research positions at Yale University School of Medicine and the University of California, Los Angeles.  He is a fellow of the Royal College of Pathologists, London and member of several distinguished societies. He has extensive experience in the discovery and development of innovative protein-based biotherapeutics in many disease areas.
  • Arthur D. Riggs, PhD, Director Emeritus and current Chair of the Diabetes Research Department of the Beckman Research Institute at City of Hope. Dr. Riggs was the founding dean of the City of Hope's graduate school.  He is also a Member of the National Academy of Sciences. Previously, Dr. Riggs worked with Genentech to express the first artificial genes, for somatostatin and insulin, in bacteria.  His work helped form the bedrock of the modern biotechnology industry, enabling the large-scale manufacture of protein drugs, like synthetic human insulin, and developing recombinant DNA techniques that are the basis for creating therapeutic monoclonal antibodies.
  • John C. Williams, PhD, Co-founder of Meditope Biosciences and Associate Professor of Molecular Medicine at the Beckman Research Institute of the City of Hope, where he also serves as a member of the Developmental Cancer Therapeutics Program as well
    '/>"/>

  • SOURCE Meditope Biosciences, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
    2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
    3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
    4. Neurocrine Biosciences Reports First Quarter 2012 Results
    5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
    6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
    7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
    8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
    9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
    10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
    11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
    (Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness & ... Center by the Medical Fitness Association, a non-profit organization ... their full potential. The Cadence Fitness & Health Center ... suburbs and second in the Chicagoland area. ...
    (Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
    Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
    ... Reportlinker.com announces that a new market ... Growth Hormone Deficiency Global ... http://www.reportlinker.com/p0567405/Growth-Hormone-Deficiency-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development Growth ... 2011 Summary ...
    ... 2011 ImpactRx, the pioneer in ... behavior, offers pharmaceutical brand managers unique insight into ... proprietary database, ImpactData™, annually captures more than 250,000 ... physicians, treatment behavior in response to these requests ...
    Cached Medicine Technology:Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 2Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 3Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 4Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 5Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 6Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 7Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 8Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011 9ImpactRx Measures How Patient Brand Requests Drive Physician Treatment Decisions 2
    (Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
    (Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
    (Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
    (Date:4/17/2014)... has created a new technology for modifying human ... the body and selectively target cancer and other ... that monitor and modify human physiology is a ... existing technology enabled bioengineers to build such devices ... in a customized fashion. , "The project addressed ...
    (Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
    Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
    ... Health Plans of America (MHPA) Executive Director ... proposed elimination of California,s State Children,s Health Insurance Program ... Governor,s proposal to eliminate the Healthy Families program would ... the federal government has just approved a major expansion ...
    ... led by conservative political operative with ties to convicted lobbyist ... Public Campaign Action Fund issued a new investigative report today ... group behind the political ads running in eight states, including ... funded by the Americans for Prosperity Foundation, which has a ...
    ... with ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including Nebraska, to oppose health care reform. ... which has a record as a right-wing political operation and ...
    ... Study findings could have lifesaving potential , MONDAY, June ... sleep during colonoscopy results in more frequent detection of ... new research has found. , During colonoscopy, patients can ... kept awake using moderate conscious sedation, which allows them ...
    ... Reducing Health Risks , , EAU CLAIRE, Wisc., June ... aren,t typically at risk for stroke, but lifestyle habits developed ... program run by Sacred Heart Hospital offers elementary school-aged children ... with parents and the administration at St. Mary,s and St. ...
    ... , Tate & Lyle will not appeal ITC decision; Voluntarily dismisses ... Changzhou Niutang , one of the largest global ... US Niutang, today announced that Tate & Lyle will not appeal ... decisively rejected Tate & Lyle,s infringement allegations against Niutang ...
    Cached Medicine News:Health News:MHPA, Leading Association Representing Medicaid Health Plans, Issues Statement on Proposed California SCHIP Elimination 2Health News:'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Montana 2Health News:'Viewers Beware' Report By Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running In Nebraska 2Health News:Deep Sleep May Improve Colonoscopy Results 2Health News:Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age 2Health News:Niutang Sucralose Patent Litigation Successfully Concluded 2Health News:Niutang Sucralose Patent Litigation Successfully Concluded 3
    ... PC captures, displays, replays and analyzes ... proven to be effective in evaluating ... obstructive pulmonary disease.,It provides objective evidence ... , , Waveform and time-expanded ...
    ... youre faced with the challenge of,controlling ... and timely patient data,management is critical. ... reliable,access to important clinical information,wherever you ... AND GO concept,makes your job easier. ...
    ... System is a multifunctional hybrid configuration, ... Accelerator and a SOMATOM CT Scanner ... image guidance to radiation treatment delivery, ... within the treatment room. The Siemens ...
    ... a web-enabled PACS that has built-in ... workflow integration. It is a multi-modality ... archives images, reports and clinical data ... non-DICOM devices and gives Cardiologists a ...
    Medicine Products: